28 min listen
Interdisciplinary Cancer Team Series Module 2: A Multi-Institutional Review of Contralateral Axillary Metastases: Time for Reclassification as a Local…
FromSurgOnc Today®
Interdisciplinary Cancer Team Series Module 2: A Multi-Institutional Review of Contralateral Axillary Metastases: Time for Reclassification as a Local…
FromSurgOnc Today®
ratings:
Length:
11 minutes
Released:
Oct 26, 2023
Format:
Podcast episode
Description
This episode of SurgOnc Today®, features guest faculty, Astrid Botty Van Den Bruele, MD, and Meghan Flanagan, MD, MPH. In a contemporary group of patients diagnosed with contralateral axillary metastases (CAM), those selected for treatment with presumed curative intent experienced improved OS when compared to stage IV (M1) patients. The current literature, as well as some forthcoming data, adds additional support for re-evaluating the stage IV designation, in favor of N3, and consideration of curative intent treatment in this disease entity.
Released:
Oct 26, 2023
Format:
Podcast episode
Titles in the series (99)
Practice Changing Studies in Melanoma Surgical Oncology: Tina J. Hieken, MD, Vice Chair of the SSO Melanoma Disease Site Work Group, moderates as Melanoma DSWG members, Jessica Cintolo-Gonzalez, MD, and Kelly Olino, MD, present practice changing studies from 2019. by SurgOnc Today®